Immunome (IMNM) Current Assets (2023 - 2025)
Historic Current Assets for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $279.9 million.
- Immunome's Current Assets rose 1470.41% to $279.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $279.9 million, marking a year-over-year increase of 1470.41%. This contributed to the annual value of $221.3 million for FY2024, which is 5296.09% up from last year.
- Latest data reveals that Immunome reported Current Assets of $279.9 million as of Q3 2025, which was up 1470.41% from $277.4 million recorded in Q2 2025.
- In the past 5 years, Immunome's Current Assets registered a high of $323.1 million during Q1 2025, and its lowest value of $39.5 million during Q2 2023.
- Over the past 3 years, Immunome's median Current Assets value was $244.0 million (recorded in 2024), while the average stood at $206.0 million.
- In the last 5 years, Immunome's Current Assets soared by 61923.29% in 2024 and then plummeted by 241.03% in 2025.
- Quarter analysis of 3 years shows Immunome's Current Assets stood at $144.7 million in 2023, then soared by 52.96% to $221.3 million in 2024, then rose by 26.47% to $279.9 million in 2025.
- Its Current Assets was $279.9 million in Q3 2025, compared to $277.4 million in Q2 2025 and $323.1 million in Q1 2025.